Trial Profile
A phase 3 multicenter study to assess the efficacy and safety of etanercept 50 mg twice weekly in psoriasis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Aug 2017
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Amgen
- 03 Aug 2017 Results of pooled analysis of 10 trials (NCT00245960, NCT00111449, NCT00663052, NCT00454584) generating evidence concerning the number of patients dropping out of etanercept trials published in the British Journal of Dermatology
- 08 Feb 2011 Results presented at the 69th Annual Meeting of the American Academy of Dermatology.
- 19 Apr 2008 New trial record.